Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vulnerable plaque: definition, detection, treatment, and future implications.

Kerem Ozer1, Mehmet Cilingiroglu

  • 1Department of Medicine, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA.

Current Atherosclerosis Reports
|February 25, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Does Height Influence the Effectiveness of Beta-Blocker Therapy after Myocardial Infarction?

Cardiology·2026
Same author

Lower Risk of Cardiovascular Events in Patients With Clinical Atherosclerotic Cardiovascular Disease Who Initiated Semaglutide 2.4 mg in the Real-World: Results From the SCORE-Clinical ASCVD Study.

Diabetes, obesity & metabolism·2026
Same author

Editorial: Epicardial-only left atrial appendage closure: Insights from seven years of first-in-human experience.

Cardiovascular revascularization medicine : including molecular interventions·2026
Same author

Editorial: Do we still need routine pre-discharge echocardiography after LAAC?

Cardiovascular revascularization medicine : including molecular interventions·2026
Same author

Semaglutide and tirzepatide effects on cardiovascular outcomes in people with overweight or obesity in the real world (STEER).

Diabetes, obesity & metabolism·2026
Same author

Cardio-oncology Outcomes in Ultrasound-assisted Versus Standard Catheter-directed Thrombolysis for Acute Pulmonary Embolus.

Journal of the Society for Cardiovascular Angiography & Interventions·2025

Identifying vulnerable plaque in coronary atherosclerosis remains a challenge. This review explores methods for diagnosing vulnerable plaque in vivo to better assess cardiovascular risk.

Area of Science:

  • Cardiovascular Medicine
  • Medical Imaging
  • Pathology

Background:

  • Atherosclerosis is a leading cause of global morbidity and mortality.
  • Coronary artery disease accounts for a significant proportion of atherosclerosis-related deaths.
  • Optimal in vivo diagnosis of vulnerable plaque is currently lacking.

Purpose of the Study:

  • To define critical lesions in coronary atherosclerosis.
  • To review methods for detecting vulnerable plaque in vivo.
  • To assess the clinical utility and future implications of these detection methods.

Main Methods:

  • Literature review of existing and emerging technologies for vulnerable plaque detection.
  • Analysis of the advantages and clinical potential of various diagnostic methods.

Related Experiment Videos

  • Discussion of the relationship between lesion characteristics and cardiovascular risk.

    • Main Results:

    • Current diagnostic methods for vulnerable plaque have limitations.
    • Several promising technologies are under investigation for improved in vivo detection.
    • Accurate identification of vulnerable lesions is crucial for risk stratification.

    Conclusions:

    • There is a critical need for improved in vivo methods to diagnose vulnerable atherosclerotic plaque.
    • Advancements in detection technologies hold significant potential for clinical application.
    • Better diagnosis of vulnerable plaque could lead to more effective cardiovascular risk management.